Case report: dual primary AIDS-defining cancers in an HIV-infected patient receiving antiretroviral therapy: Burkitt's lymphoma and Kaposi's sarcoma
- PMID: 30409111
- PMCID: PMC6225729
- DOI: 10.1186/s12885-018-5019-9
Case report: dual primary AIDS-defining cancers in an HIV-infected patient receiving antiretroviral therapy: Burkitt's lymphoma and Kaposi's sarcoma
Abstract
Background: The incidence of AIDS-defining cancers (ADCs) has decreased markedly in the era of highly active antiretroviral therapy (HAART). The occurrence of two ADCs is rare in people living with HIV or AIDS (PWHA) who are severely immunosuppressed or have incomplete virologic suppression.
Case presentation: We report a case of dual primary ADCs, especially NHL followed by KS, in a 70-year-old HIV-infected man who was on antiretroviral therapy and had successful virologic suppression. During HAART, he presented with generalized myalgia and abdominal pain. Multiple liver masses were detected and a biopsy revealed Burkitt's lymphoma. After three cycles of anticancer chemotherapy with a favorable response, he was diagnosed with cytomegalovirus retinitis and the anti-cancer chemotherapy was discontinued. Despite successful virologic suppression with HAART, human herpes virus-8 associated Kaposi's sarcoma was diagnosed in his right thigh. He underwent radiation therapy.
Conclusion: These findings suggest that multiple ADCs can occur in PWHA who are receiving HAART and have successful virologic suppression. Healthcare providers caring for PWHA should maintain vigilance for the development of a broad spectrum of cancers.
Keywords: Antiretroviral therapy; Burkitt’s lymphoma; HIV; Kaposi’s sarcoma.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Written consent to publish this case report was obtained from the patient (Consent No. 2017-JN24).
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.J Korean Med Sci. 2017 Sep;32(9):1445-1450. doi: 10.3346/jkms.2017.32.9.1445. J Korean Med Sci. 2017. PMID: 28776339 Free PMC article.
-
Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.Cochrane Database Syst Rev. 2014;(9):CD003256. doi: 10.1002/14651858.CD003256.pub2. Cochrane Database Syst Rev. 2014. PMID: 25313415 Review.
-
The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.AIDS. 2011 Feb 20;25(4):463-71. doi: 10.1097/QAD.0b013e32834344e6. AIDS. 2011. PMID: 21139489 Free PMC article.
-
Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.J Invest Dermatol. 2001 Oct;117(4):858-63. doi: 10.1046/j.0022-202x.2001.01465.x. J Invest Dermatol. 2001. PMID: 11676823
-
Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.Cochrane Database Syst Rev. 2014 Aug 13;8(8):CD003256. doi: 10.1002/14651858.CD003256.pub2. Cochrane Database Syst Rev. 2014. PMID: 25221796 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention HIV surveillance - United States, 1981-2008. MMWR Morb Mortal Wkly Rep. 2011;60:689–693. - PubMed
-
- Mortality GBD, Causes of Death C Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1459–1544. doi: 10.1016/S0140-6736(16)31012-1. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical